

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of protein polyubiquitination (GO:1902914) | 9.01563264 |
| 2 | catecholamine transport (GO:0051937) | 7.98730847 |
| 3 | neurotransmitter uptake (GO:0001504) | 7.47633484 |
| 4 | negative regulation of actin filament bundle assembly (GO:0032232) | 7.38540019 |
| 5 | regulation of mitochondrial fission (GO:0090140) | 7.32235715 |
| 6 | startle response (GO:0001964) | 7.11647739 |
| 7 | norepinephrine metabolic process (GO:0042415) | 7.10428873 |
| 8 | response to manganese ion (GO:0010042) | 6.46748200 |
| 9 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.27372206 |
| 10 | zinc ion homeostasis (GO:0055069) | 5.88156203 |
| 11 | regulation of mitochondrial translation (GO:0070129) | 5.85341155 |
| 12 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 5.79331401 |
| 13 | L-fucose catabolic process (GO:0042355) | 5.31552861 |
| 14 | fucose catabolic process (GO:0019317) | 5.31552861 |
| 15 | L-fucose metabolic process (GO:0042354) | 5.31552861 |
| 16 | cellular response to ammonium ion (GO:0071242) | 5.29722978 |
| 17 | monoamine transport (GO:0015844) | 5.20606923 |
| 18 | cellular response to catecholamine stimulus (GO:0071870) | 4.55590580 |
| 19 | cellular response to monoamine stimulus (GO:0071868) | 4.55590580 |
| 20 | regulation of dopamine secretion (GO:0014059) | 4.54788552 |
| 21 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 4.40316704 |
| 22 | regulation of actin nucleation (GO:0051125) | 4.38321575 |
| 23 | mitochondrion degradation (GO:0000422) | 4.35588773 |
| 24 | cellular response to toxic substance (GO:0097237) | 4.11334398 |
| 25 | cellular protein catabolic process (GO:0044257) | 4.06288298 |
| 26 | intra-S DNA damage checkpoint (GO:0031573) | 4.04112929 |
| 27 | phenylpropanoid metabolic process (GO:0009698) | 3.96724147 |
| 28 | positive regulation of DNA binding (GO:0043388) | 3.94882382 |
| 29 | response to monoamine (GO:0071867) | 3.93606526 |
| 30 | response to catecholamine (GO:0071869) | 3.93606526 |
| 31 | negative regulation of cellular carbohydrate metabolic process (GO:0010677) | 3.92399615 |
| 32 | apical protein localization (GO:0045176) | 3.88136156 |
| 33 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.84443691 |
| 34 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.80575979 |
| 35 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 3.66899647 |
| 36 | response to pheromone (GO:0019236) | 3.58340805 |
| 37 | nitric oxide mediated signal transduction (GO:0007263) | 3.56840845 |
| 38 | dopamine metabolic process (GO:0042417) | 3.53676965 |
| 39 | platelet dense granule organization (GO:0060155) | 3.52838339 |
| 40 | xenobiotic catabolic process (GO:0042178) | 3.51475542 |
| 41 | protein import into peroxisome matrix (GO:0016558) | 3.49909507 |
| 42 | neuromuscular process controlling posture (GO:0050884) | 3.46484174 |
| 43 | mitochondrial fission (GO:0000266) | 3.41050528 |
| 44 | nitric oxide biosynthetic process (GO:0006809) | 3.34706855 |
| 45 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.31801241 |
| 46 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 3.20152870 |
| 47 | negative regulation of carbohydrate metabolic process (GO:0045912) | 3.19134589 |
| 48 | interkinetic nuclear migration (GO:0022027) | 3.17029150 |
| 49 | positive regulation of response to cytokine stimulus (GO:0060760) | 3.11492555 |
| 50 | protein K63-linked ubiquitination (GO:0070534) | 3.03748516 |
| 51 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.96135281 |
| 52 | negative regulation of insulin secretion (GO:0046676) | 2.92240983 |
| 53 | cellular response to interferon-beta (GO:0035458) | 2.87497817 |
| 54 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.85269661 |
| 55 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.85011820 |
| 56 | endocrine pancreas development (GO:0031018) | 2.78580133 |
| 57 | signal peptide processing (GO:0006465) | 2.77690131 |
| 58 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.75677914 |
| 59 | cellular response to vitamin D (GO:0071305) | 2.73856593 |
| 60 | DNA deamination (GO:0045006) | 2.72519533 |
| 61 | regulation of catecholamine secretion (GO:0050433) | 2.71095424 |
| 62 | protein prenylation (GO:0018342) | 2.70099457 |
| 63 | prenylation (GO:0097354) | 2.70099457 |
| 64 | detection of light stimulus involved in visual perception (GO:0050908) | 2.69160766 |
| 65 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.69160766 |
| 66 | peptidyl-histidine modification (GO:0018202) | 2.68734336 |
| 67 | positive regulation of lamellipodium organization (GO:1902745) | 2.68430041 |
| 68 | aspartate family amino acid catabolic process (GO:0009068) | 2.64691964 |
| 69 | protein autoubiquitination (GO:0051865) | 2.64598055 |
| 70 | grooming behavior (GO:0007625) | 2.64584257 |
| 71 | rRNA catabolic process (GO:0016075) | 2.62634683 |
| 72 | negative regulation of peptide hormone secretion (GO:0090278) | 2.61968885 |
| 73 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.61765269 |
| 74 | positive regulation of lamellipodium assembly (GO:0010592) | 2.60719142 |
| 75 | cytochrome complex assembly (GO:0017004) | 2.55672481 |
| 76 | negative regulation of gluconeogenesis (GO:0045721) | 2.55276500 |
| 77 | chemosensory behavior (GO:0007635) | 2.54279600 |
| 78 | C4-dicarboxylate transport (GO:0015740) | 2.54176195 |
| 79 | negative regulation of peptide secretion (GO:0002792) | 2.52284647 |
| 80 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.51109144 |
| 81 | regulation of synaptic vesicle transport (GO:1902803) | 2.50061373 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 2.49088669 |
| 83 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.47326992 |
| 84 | fucose metabolic process (GO:0006004) | 2.46397888 |
| 85 | response to hepatocyte growth factor (GO:0035728) | 2.46245171 |
| 86 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.46245171 |
| 87 | piRNA metabolic process (GO:0034587) | 2.45102595 |
| 88 | body morphogenesis (GO:0010171) | 2.42923367 |
| 89 | negative regulation of oxidative stress-induced cell death (GO:1903202) | 2.42580488 |
| 90 | hyperosmotic response (GO:0006972) | 2.41540884 |
| 91 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.41235319 |
| 92 | potassium ion export (GO:0071435) | 2.40601867 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.38911361 |
| 94 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 12.5608126 |
| 95 | protein K6-linked ubiquitination (GO:0085020) | 12.4516690 |
| 96 | regulation of glucokinase activity (GO:0033131) | 11.4741330 |
| 97 | regulation of hexokinase activity (GO:1903299) | 11.4741330 |
| 98 | dopamine transport (GO:0015872) | 10.8391336 |
| 99 | regulation of oxidative stress-induced neuron death (GO:1903203) | 10.2913888 |
| 100 | positive regulation of mitochondrial fission (GO:0090141) | 10.0737568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 5.58046456 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.39743502 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.77882676 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.84132812 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.66896118 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.63106483 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.55378082 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.50513765 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.50406684 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42566259 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40349869 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32447349 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31913961 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.19812401 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09156684 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.08026307 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07251873 |
| 18 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.01782167 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98011330 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.95861313 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92388087 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92367069 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80356039 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79249272 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78026900 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71284663 |
| 27 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61810382 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61079021 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58970944 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.58024823 |
| 31 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.56729888 |
| 32 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.54602065 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53061756 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52988326 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52988326 |
| 36 | NCOR_22424771_ChIP-Seq_293T_Human | 1.52708663 |
| 37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51661039 |
| 38 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.50191043 |
| 39 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.47128320 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46361785 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43381282 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41593563 |
| 43 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.39066196 |
| 44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38548422 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34795294 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34153920 |
| 47 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.31349129 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.31121005 |
| 49 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.29237158 |
| 50 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.26616333 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26493257 |
| 52 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25591770 |
| 53 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.25449302 |
| 54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24645660 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24377654 |
| 56 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24190504 |
| 57 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23851877 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21672138 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21621624 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20560872 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20214035 |
| 62 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.19976771 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17271275 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16934390 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16891128 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16342176 |
| 67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14287788 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14287788 |
| 69 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14239173 |
| 70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13164573 |
| 71 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13164573 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12674593 |
| 73 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12666516 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12510189 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10523137 |
| 76 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.10035433 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09593001 |
| 78 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07438281 |
| 79 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07086993 |
| 80 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06774746 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06675488 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06443126 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04955763 |
| 84 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.04620974 |
| 85 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04510789 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04172387 |
| 87 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04108624 |
| 88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03620210 |
| 89 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.03146335 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02834661 |
| 91 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01402264 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00948061 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00813858 |
| 94 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00312569 |
| 95 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.00183635 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00118883 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98528413 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.97284632 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96893102 |
| 100 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.96520421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 4.77695147 |
| 2 | MP0003195_calcinosis | 4.60499685 |
| 3 | MP0003283_abnormal_digestive_organ | 3.54039502 |
| 4 | MP0008995_early_reproductive_senescence | 3.46912937 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.24717952 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 3.22658555 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.94260770 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.85873667 |
| 9 | MP0003879_abnormal_hair_cell | 2.79715792 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.78064742 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.64722808 |
| 12 | MP0003787_abnormal_imprinting | 2.41596744 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.40875364 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.35453482 |
| 15 | MP0005220_abnormal_exocrine_pancreas | 2.35421254 |
| 16 | MP0003186_abnormal_redox_activity | 2.30799058 |
| 17 | MP0004885_abnormal_endolymph | 2.24462208 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.21791646 |
| 19 | MP0003123_paternal_imprinting | 2.15595815 |
| 20 | MP0001905_abnormal_dopamine_level | 1.97774724 |
| 21 | MP0006292_abnormal_olfactory_placode | 1.97182116 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.93055921 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.84926104 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.71744463 |
| 25 | MP0004147_increased_porphyrin_level | 1.65356019 |
| 26 | MP0009785_altered_susceptibility_to | 1.65037635 |
| 27 | MP0002272_abnormal_nervous_system | 1.63981161 |
| 28 | MP0008004_abnormal_stomach_pH | 1.63246049 |
| 29 | MP0000470_abnormal_stomach_morphology | 1.57725916 |
| 30 | MP0005365_abnormal_bile_salt | 1.49905789 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.48536314 |
| 32 | MP0001873_stomach_inflammation | 1.48208502 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.47658708 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.47240400 |
| 35 | MP0009764_decreased_sensitivity_to | 1.44880600 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.42026720 |
| 37 | MP0005671_abnormal_response_to | 1.41853070 |
| 38 | MP0001944_abnormal_pancreas_morphology | 1.41704147 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.41210009 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.40225719 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.38687481 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.33450508 |
| 43 | MP0003866_abnormal_defecation | 1.33294036 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.32060665 |
| 45 | MP0003786_premature_aging | 1.32059642 |
| 46 | MP0006054_spinal_hemorrhage | 1.27444693 |
| 47 | MP0002163_abnormal_gland_morphology | 1.25210558 |
| 48 | MP0005410_abnormal_fertilization | 1.24513038 |
| 49 | MP0001664_abnormal_digestion | 1.23541399 |
| 50 | MP0005535_abnormal_body_temperature | 1.19955523 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.19428898 |
| 52 | MP0005083_abnormal_biliary_tract | 1.18013151 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.16748175 |
| 54 | MP0009745_abnormal_behavioral_response | 1.14981259 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.07450205 |
| 56 | MP0004381_abnormal_hair_follicle | 1.07118921 |
| 57 | MP0002229_neurodegeneration | 1.06588357 |
| 58 | MP0008872_abnormal_physiological_respon | 1.06468802 |
| 59 | MP0003959_abnormal_lean_body | 1.04566414 |
| 60 | MP0005647_abnormal_sex_gland | 1.01031829 |
| 61 | MP0002928_abnormal_bile_duct | 0.99809475 |
| 62 | MP0001835_abnormal_antigen_presentation | 0.98050537 |
| 63 | MP0005253_abnormal_eye_physiology | 0.97158193 |
| 64 | MP0001188_hyperpigmentation | 0.96329593 |
| 65 | MP0005332_abnormal_amino_acid | 0.95275999 |
| 66 | MP0001486_abnormal_startle_reflex | 0.93881509 |
| 67 | MP0003137_abnormal_impulse_conducting | 0.90789049 |
| 68 | MP0003633_abnormal_nervous_system | 0.89573893 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.85791501 |
| 70 | MP0001440_abnormal_grooming_behavior | 0.84697097 |
| 71 | MP0000343_altered_response_to | 0.84618161 |
| 72 | MP0003953_abnormal_hormone_level | 0.82288384 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.81047610 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 0.80442884 |
| 75 | MP0003119_abnormal_digestive_system | 0.80335465 |
| 76 | MP0000462_abnormal_digestive_system | 0.80219965 |
| 77 | MP0000749_muscle_degeneration | 0.80164355 |
| 78 | MP0004084_abnormal_cardiac_muscle | 0.78677328 |
| 79 | MP0010155_abnormal_intestine_physiology | 0.78309331 |
| 80 | MP0005025_abnormal_response_to | 0.76255712 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 0.74324664 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.72434044 |
| 83 | MP0002210_abnormal_sex_determination | 0.72430225 |
| 84 | MP0005187_abnormal_penis_morphology | 0.72107483 |
| 85 | MP0001501_abnormal_sleep_pattern | 0.71918877 |
| 86 | MP0003698_abnormal_male_reproductive | 0.70145347 |
| 87 | MP0001661_extended_life_span | 0.70051338 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.69979692 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.69129399 |
| 90 | MP0000427_abnormal_hair_cycle | 0.68632102 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.66849291 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.66155666 |
| 93 | MP0010329_abnormal_lipoprotein_level | 0.64330927 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.64271887 |
| 95 | MP0000358_abnormal_cell_content/ | 0.64198278 |
| 96 | MP0001984_abnormal_olfaction | 0.63548448 |
| 97 | MP0005448_abnormal_energy_balance | 0.63382853 |
| 98 | MP0009697_abnormal_copulation | 0.62545796 |
| 99 | MP0004130_abnormal_muscle_cell | 0.60372894 |
| 100 | MP0001145_abnormal_male_reproductive | 0.59953139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 8.64508227 |
| 2 | Hypoplasia of the fovea (HP:0007750) | 8.64508227 |
| 3 | Anterior segment dysgenesis (HP:0007700) | 7.93217173 |
| 4 | Abnormality of the fovea (HP:0000493) | 6.89834595 |
| 5 | Alveolar cell carcinoma (HP:0006519) | 5.88153911 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.70373956 |
| 7 | Germ cell neoplasia (HP:0100728) | 5.42674791 |
| 8 | Neoplasm of the tracheobronchial system (HP:0100552) | 5.32546479 |
| 9 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.30339146 |
| 10 | Genetic anticipation (HP:0003743) | 4.92912720 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.30601141 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.85705000 |
| 13 | Abnormal pancreas size (HP:0012094) | 3.83727997 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.63810559 |
| 15 | Breast carcinoma (HP:0003002) | 3.49884578 |
| 16 | Scanning speech (HP:0002168) | 3.35477409 |
| 17 | Autoimmune hemolytic anemia (HP:0001890) | 3.31636927 |
| 18 | Stomatitis (HP:0010280) | 3.16308181 |
| 19 | Methylmalonic acidemia (HP:0002912) | 3.08908156 |
| 20 | Postural instability (HP:0002172) | 3.04899770 |
| 21 | Abnormal drinking behavior (HP:0030082) | 3.04681379 |
| 22 | Polydipsia (HP:0001959) | 3.04681379 |
| 23 | Abnormality of homocysteine metabolism (HP:0010919) | 2.99422626 |
| 24 | Homocystinuria (HP:0002156) | 2.99422626 |
| 25 | Abnormality of B cell number (HP:0010975) | 2.99389439 |
| 26 | Hypoglycemic coma (HP:0001325) | 2.97464351 |
| 27 | Polyuria (HP:0000103) | 2.94730039 |
| 28 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.83647175 |
| 29 | Dysmetric saccades (HP:0000641) | 2.80777431 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.76693300 |
| 31 | Abnormality of the anterior chamber (HP:0000593) | 2.76414864 |
| 32 | Abnormality of the line of Schwalbe (HP:0008048) | 2.73344140 |
| 33 | Posterior embryotoxon (HP:0000627) | 2.71012851 |
| 34 | Albinism (HP:0001022) | 2.65716302 |
| 35 | Rectal fistula (HP:0100590) | 2.60462544 |
| 36 | Rectovaginal fistula (HP:0000143) | 2.60462544 |
| 37 | Agitation (HP:0000713) | 2.57315992 |
| 38 | Symptomatic seizures (HP:0011145) | 2.53679247 |
| 39 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.53587510 |
| 40 | Febrile seizures (HP:0002373) | 2.52881807 |
| 41 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.48317189 |
| 42 | Severe muscular hypotonia (HP:0006829) | 2.47733302 |
| 43 | Abnormality of vitamin B metabolism (HP:0004340) | 2.44557832 |
| 44 | Late onset (HP:0003584) | 2.43928616 |
| 45 | Limb hypertonia (HP:0002509) | 2.42722871 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.41704667 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 2.39569699 |
| 48 | Hypothermia (HP:0002045) | 2.38277110 |
| 49 | Abnormal urine output (HP:0012590) | 2.37929549 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.36565361 |
| 51 | Abnormality of the parathyroid morphology (HP:0011766) | 2.32978946 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31555691 |
| 53 | Thyroiditis (HP:0100646) | 2.27537771 |
| 54 | Increased circulating renin level (HP:0000848) | 2.26787256 |
| 55 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.24508688 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.23420619 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.23288733 |
| 58 | Congenital stationary night blindness (HP:0007642) | 2.17619310 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.16479925 |
| 60 | Intestinal fistula (HP:0100819) | 2.14089515 |
| 61 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11770214 |
| 62 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09963397 |
| 63 | Vaginal fistula (HP:0004320) | 2.04564967 |
| 64 | Abnormality of renal excretion (HP:0011036) | 2.04529924 |
| 65 | B lymphocytopenia (HP:0010976) | 2.03166220 |
| 66 | Increased IgM level (HP:0003496) | 2.02922986 |
| 67 | Hyperglycemia (HP:0003074) | 2.01550717 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00751938 |
| 69 | Azoospermia (HP:0000027) | 1.97993591 |
| 70 | Neoplasm of the lung (HP:0100526) | 1.97707808 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 1.96782954 |
| 72 | Abnormality of midbrain morphology (HP:0002418) | 1.96782954 |
| 73 | Abnormality of saccadic eye movements (HP:0000570) | 1.96028495 |
| 74 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.94879477 |
| 75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94481961 |
| 76 | Abnormality of vitamin metabolism (HP:0100508) | 1.92035784 |
| 77 | Abnormality of lateral ventricle (HP:0030047) | 1.88811970 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86176394 |
| 79 | Tubular atrophy (HP:0000092) | 1.84892307 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84832342 |
| 81 | Esotropia (HP:0000565) | 1.84457647 |
| 82 | Tachypnea (HP:0002789) | 1.84243220 |
| 83 | Brushfield spots (HP:0001088) | 1.83779599 |
| 84 | Steatorrhea (HP:0002570) | 1.82342567 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 1.79462815 |
| 86 | Neoplasm of the respiratory system (HP:0100606) | 1.77818203 |
| 87 | Hypoproteinemia (HP:0003075) | 1.76550936 |
| 88 | Ovarian neoplasm (HP:0100615) | 1.76493498 |
| 89 | Restlessness (HP:0000711) | 1.74203573 |
| 90 | Slow saccadic eye movements (HP:0000514) | 1.73812122 |
| 91 | Tubulointerstitial fibrosis (HP:0005576) | 1.72329835 |
| 92 | Eosinophilia (HP:0001880) | 1.71589707 |
| 93 | Hyperventilation (HP:0002883) | 1.67797996 |
| 94 | Tongue fasciculations (HP:0001308) | 1.67110029 |
| 95 | Abnormality of eosinophils (HP:0001879) | 1.65634019 |
| 96 | Disproportionate short-trunk short stature (HP:0003521) | 1.63521948 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.63293430 |
| 98 | Dysdiadochokinesis (HP:0002075) | 1.63238952 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 1.62881061 |
| 100 | Increased CSF lactate (HP:0002490) | 1.62364886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 2.95803231 |
| 2 | TESK2 | 2.74829260 |
| 3 | FRK | 2.35745062 |
| 4 | CASK | 2.28087012 |
| 5 | EIF2AK3 | 2.19310344 |
| 6 | STK10 | 2.03339029 |
| 7 | PINK1 | 12.6329621 |
| 8 | NUAK1 | 1.88537624 |
| 9 | PIK3CA | 1.83360599 |
| 10 | EIF2AK1 | 1.75286909 |
| 11 | TRIM28 | 1.65803311 |
| 12 | KSR1 | 1.64326528 |
| 13 | MST4 | 1.63278520 |
| 14 | MARK3 | 1.51219552 |
| 15 | ADRBK2 | 1.48923323 |
| 16 | GRK1 | 1.35571852 |
| 17 | TAOK3 | 1.31369581 |
| 18 | AKT3 | 1.28647455 |
| 19 | PTK2B | 1.23924678 |
| 20 | DYRK3 | 1.22802859 |
| 21 | LRRK2 | 1.21856279 |
| 22 | MAPKAPK3 | 1.14046452 |
| 23 | ZAK | 1.11407367 |
| 24 | TSSK6 | 1.10828572 |
| 25 | TXK | 1.09700388 |
| 26 | STK3 | 1.09216920 |
| 27 | SIK3 | 1.07362573 |
| 28 | RPS6KB2 | 1.02460194 |
| 29 | IKBKE | 1.01494077 |
| 30 | STK39 | 0.98074608 |
| 31 | BMPR1B | 0.87068461 |
| 32 | SGK2 | 0.86450461 |
| 33 | OXSR1 | 0.85844331 |
| 34 | FER | 0.83063979 |
| 35 | GRK7 | 0.79181476 |
| 36 | TYK2 | 0.78537778 |
| 37 | ITK | 0.76453710 |
| 38 | WNK3 | 0.74088317 |
| 39 | TBK1 | 0.72933655 |
| 40 | PRKCI | 0.66550668 |
| 41 | STK38L | 0.65821195 |
| 42 | SGK494 | 0.64534571 |
| 43 | SGK223 | 0.64534571 |
| 44 | JAK3 | 0.63959389 |
| 45 | TEC | 0.62816130 |
| 46 | CLK1 | 0.61497494 |
| 47 | BCR | 0.56914709 |
| 48 | CDC42BPA | 0.53384379 |
| 49 | STK4 | 0.51420274 |
| 50 | STK11 | 0.51007639 |
| 51 | ADRBK1 | 0.50518325 |
| 52 | PRKCQ | 0.49065073 |
| 53 | VRK1 | 0.48111437 |
| 54 | MINK1 | 0.47615040 |
| 55 | KDR | 0.46342505 |
| 56 | PAK3 | 0.44867248 |
| 57 | NLK | 0.43429341 |
| 58 | PLK3 | 0.42073567 |
| 59 | ERBB3 | 0.41641167 |
| 60 | NEK1 | 0.41408606 |
| 61 | PRKCG | 0.40623573 |
| 62 | CDK8 | 0.39008772 |
| 63 | HIPK2 | 0.37465002 |
| 64 | SGK3 | 0.37378180 |
| 65 | CSNK1A1 | 0.37020789 |
| 66 | TESK1 | 0.36161286 |
| 67 | IKBKB | 0.35455998 |
| 68 | NEK6 | 0.35241796 |
| 69 | PIM1 | 0.35212326 |
| 70 | NME1 | 0.34005672 |
| 71 | PHKG2 | 0.33111930 |
| 72 | PHKG1 | 0.33111930 |
| 73 | ROCK1 | 0.32416132 |
| 74 | TLK1 | 0.32189662 |
| 75 | MAP3K8 | 0.29974254 |
| 76 | FGFR1 | 0.29590958 |
| 77 | PRKCE | 0.29137445 |
| 78 | STK24 | 0.28962004 |
| 79 | LCK | 0.28483629 |
| 80 | ABL1 | 0.26380236 |
| 81 | MAPKAPK5 | 0.26204765 |
| 82 | ROCK2 | 0.25582011 |
| 83 | BLK | 0.25487777 |
| 84 | KIT | 0.25104081 |
| 85 | CAMK2D | 0.24789755 |
| 86 | FES | 0.24657247 |
| 87 | RPS6KB1 | 0.24194333 |
| 88 | BTK | 0.19504250 |
| 89 | TAOK1 | 0.19387920 |
| 90 | CHUK | 0.19154247 |
| 91 | CAMK2A | 0.15159374 |
| 92 | LIMK1 | 0.14739329 |
| 93 | TRPM7 | 0.14173641 |
| 94 | JAK1 | 0.14060213 |
| 95 | MYLK | 0.13780311 |
| 96 | NTRK3 | 0.13680484 |
| 97 | ERBB2 | 0.13680039 |
| 98 | MAP3K12 | 0.12920396 |
| 99 | CDK12 | 0.12136279 |
| 100 | PRKACA | 0.11741627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.37648085 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.82731523 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.24544598 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34157950 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.28781562 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.21547993 |
| 7 | Peroxisome_Homo sapiens_hsa04146 | 2.09475187 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.07849666 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.01235561 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.93955509 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91715489 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79225459 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64842307 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64157401 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62811712 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60195828 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58578426 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52557658 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47289631 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.46593027 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43579781 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.41729519 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40825681 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37034598 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27546960 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.26603886 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20437717 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17626202 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17160504 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10249104 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08596749 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08208009 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.06764181 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06687810 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05491254 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.02976595 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01663729 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97638988 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96208107 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94287814 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89421662 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87732052 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84583491 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84308484 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81408173 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 0.80036124 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79955411 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79288942 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79113144 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74810847 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.74564631 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74146309 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.71983347 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71948682 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.71214576 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70277597 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69721839 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68049485 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67622304 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67567854 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66662538 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66514430 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66236982 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66107172 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63340552 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.63241603 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62452245 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62359693 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61395006 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61248077 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60100423 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59011991 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57907114 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57345529 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56891873 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.55455584 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55326431 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.55150071 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54743926 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54408500 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53709748 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49578007 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.48300341 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47290973 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46485574 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46321580 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45986352 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43882493 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43772083 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42001514 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41847623 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41306468 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38859804 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36474973 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36294718 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35519767 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.34813038 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34428061 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.32535616 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31941370 |

